+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Smart Biopsy Devices Market - Global Forecast 2026-2032- Product Image
Smart Biopsy Devices Market - Global Forecast 2026-2032- Product Image
Sale

Smart Biopsy Devices Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011802
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Smart Biopsy Devices Market is projected to reach USD 6.22 Billion in 2026. It is expected to continue growing at a CAGR of 6.53%, reaching USD 9.11 Billion by 2032.

Smart biopsy devices are becoming central to precision oncology as health systems work to diagnose cancer earlier, reduce repeat procedures, and obtain higher-quality tissue for molecular testing. The clinical need is substantial: the International Agency for Research on Cancer reported nearly 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, reinforcing the importance of accurate, minimally invasive tissue acquisition.

The market spans image-guided biopsy systems, vacuum-assisted biopsy devices, robotic and navigation-enabled platforms, smart needles, integrated sensing tools, and software that supports targeting, sampling confirmation, workflow documentation, and pathology coordination. Demand is strongest where screening programs, interventional radiology capacity, and tumor profiling are expanding together, particularly as tissue adequacy becomes essential for next-generation sequencing, immunohistochemistry, and companion diagnostic selection.

Transformative Shifts in the Smart Biopsy Landscape

The smart biopsy devices landscape is shifting from procedure-specific hardware toward connected, data-enabled diagnostic ecosystems. Hospitals and specialty centers increasingly prioritize devices that improve targeting under ultrasound, CT, MRI, mammography, or endoscopic guidance while also supporting traceability, safety, and specimen adequacy.

Another major shift is the growing link between biopsy quality and downstream oncology decisions. As next-generation sequencing, immunohistochemistry, and companion diagnostics become routine in lung, breast, prostate, liver, and gastrointestinal cancers, providers need biopsy platforms that preserve tissue integrity and reduce insufficient samples. The World Health Organization’s emphasis on early cancer detection further supports the adoption of minimally invasive biopsy technologies that can shorten diagnostic pathways and improve referral efficiency.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact across the biopsy pathway rather than replacing clinicians at a single point. AI-enabled imaging can help identify suspicious lesions, support needle-path planning, improve segmentation, and standardize documentation; the U.S. FDA’s public catalog of AI/ML-enabled medical devices now includes hundreds of cleared tools, demonstrating regulatory momentum for clinical AI.

In smart biopsy devices, the strongest near-term value is decision support. AI can reduce variability in lesion localization, improve workflow efficiency, and connect imaging findings with pathology and molecular data. Adoption remains dependent on validation, cybersecurity, explainability, bias assessment, clinical governance, and integration with radiology, oncology, pathology, and hospital information systems.

Key Regional Insights: Global Adoption Patterns

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, and Australia invest in cancer screening, tertiary hospitals, digital health infrastructure, and advanced imaging capacity. The region’s adoption is supported by rising cancer incidence, broader access to CT, MRI, ultrasound, and mammography, and policy efforts to strengthen early diagnosis. North America remains a high-adoption region because of established interventional radiology networks, reimbursement pathways, FDA oversight, cancer screening utilization, and strong demand for minimally invasive cancer diagnostics that support precision medicine.

Europe benefits from organized screening programs, medical device regulation under EU MDR, and broad use of image-guided biopsy in oncology pathways, with growing emphasis on clinical evidence, post-market surveillance, and interoperability. Latin America is advancing through private hospital investment, public cancer-control programs, and rising cancer awareness, while the Middle East is supported by specialty hospital growth, national health transformation strategies, and oncology center development in Gulf economies. Africa remains underpenetrated, with opportunities tied to pathology access, imaging availability, workforce training, specimen transport systems, and affordable device and service models suited to resource-variable settings.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is shaped by expanding private healthcare, urban diagnostic centers, and government cancer-control initiatives, particularly in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, where access to advanced imaging and oncology referral networks is improving. GCC countries are adopting advanced biopsy platforms through national health transformation programs, oncology centers of excellence, medical tourism strategies, and investments in digital hospitals that support integrated imaging and pathology workflows.

The European Union is driven by harmonized quality standards, screening infrastructure, cross-border regulatory expectations, and EU MDR compliance requirements that favor robust clinical evidence and post-market monitoring. BRICS markets combine large cancer burdens with uneven access to imaging, pathology, and specialist care, creating scale opportunities for cost-effective smart biopsy systems that improve sample adequacy and reduce repeat procedures. G7 countries lead in premium adoption, AI validation, molecular oncology integration, and evidence-based procurement, while NATO member markets benefit from strong hospital procurement systems, established medtech distribution, cybersecurity expectations, and resilient healthcare infrastructure planning.

Key Country Insights: Priority Markets for Smart Biopsy Devices

The United States leads commercial adoption through high cancer screening volumes, specialty imaging centers, FDA-cleared device pathways, and broad use of molecular diagnostics, while Canada emphasizes quality, safety, and equitable access across provincial health systems. Mexico and Brazil are growing as private networks, public cancer programs, and diagnostic imaging investments expand capacity for breast, lung, prostate, liver, and gastrointestinal cancer workups.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong demand for image-guided biopsy due to organized screening, multidisciplinary oncology care, and established interventional radiology services, while Russia’s market is influenced by domestic procurement policies, regional hospital capacity, and access to advanced imaging. China and India offer major volume potential as oncology infrastructure expands, cancer awareness rises, and precision medicine adoption increases; Japan, Australia, and South Korea are advanced markets where precision diagnostics, robotics, AI-supported imaging, high-quality radiology services, and structured cancer care pathways are gaining clinical relevance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated differentiation: improved targeting accuracy, fewer non-diagnostic samples, shorter procedure times, lower complication risk, and compatibility with molecular testing. Evidence generation should include multicenter studies, real-world workflow data, usability assessments, specimen adequacy outcomes, and health-economic endpoints that appeal to hospitals, payers, and oncology networks.

Commercial strategies should align devices with imaging platforms, pathology workflows, electronic health records, and AI-enabled reporting. Vendors should localize pricing and service models for emerging markets, invest in physician and technologist training, strengthen cybersecurity and interoperability, and prepare regulatory files that address software updates, human factors, risk management, clinical performance, and post-market surveillance.

Research Methodology

This executive summary is developed using secondary research from verified public sources, including international cancer statistics, regulatory agency databases, clinical guidelines, peer-reviewed literature, product documentation, hospital procurement trends, healthcare policy references, and public health program materials.

Insights are triangulated across demand indicators, technology adoption signals, regional healthcare infrastructure, reimbursement context, clinical practice standards, and regulatory developments. The analysis emphasizes data-backed interpretation and excludes unsupported market-size, market-share, and market-forecast claims where verified public figures are not available.

Conclusion: Smart Biopsy Devices Outlook

Smart biopsy devices are evolving from mechanical sampling tools into intelligent diagnostic platforms that connect imaging, navigation, tissue acquisition, pathology, and oncology decision-making. This evolution is being accelerated by rising cancer incidence, precision medicine, AI-enabled imaging, and the need for faster, safer, and more reliable diagnosis.

Organizations that combine clinical evidence, AI readiness, workflow integration, regulatory discipline, training support, and region-specific commercialization will be best positioned. The long-term opportunity lies in helping providers obtain the right tissue, from the right target, at the right time, with confidence, efficiency, and clear value for patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Smart Biopsy Devices Market, by Technology Type
7.1. Introduction
7.2. Imaging Integrated Smart Biopsy
7.2.1. Ultrasound Integrated Systems
7.2.2. MRI Integrated Systems
7.2.3. CT Integrated Systems
7.3. Optical Biopsy Technologies
7.3.1. Fluorescence Based Biopsy
7.3.2. Spectroscopy Based Biopsy
7.4. AI Driven Biopsy Systems
8. Smart Biopsy Devices Market, by Component
8.1. Introduction
8.2. Accessories
8.2.1. Cannulas
8.2.2. Coaxial Systems
8.2.3. Markers & Clips
8.3. Localization Devices
8.4. Procedure Kits & Trays
8.5. Needle-Based Biopsy Instruments
9. Smart Biopsy Devices Market, by Procedure Type
9.1. Introduction
9.2. Minimally Invasive Biopsy
9.3. Surgical Biopsy
10. Smart Biopsy Devices Market, by Automation Level
10.1. Introduction
10.2. Manual Systems
10.3. Semi Automated Systems
10.4. Fully Automated Systems
11. Smart Biopsy Devices Market, by Application
11.1. Introduction
11.2. Breast Cancer
11.3. Liver Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
11.6. Skin Cancer
11.6.1. Melanoma Diagnosis
11.6.2. Non Melanoma Diagnosis
11.7. Gastrointestinal Cancer
11.7.1. Esophageal
11.7.2. Gastric
11.7.3. Colorectal
11.8. Kidney Cancer
12. Smart Biopsy Devices Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Diagnostic Centers
12.5. Hospitals
13. Smart Biopsy Devices Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Smart Biopsy Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Smart Biopsy Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Advin Health Care
17.2. Argon Medical Devices, Inc.
17.3. B. Braun SE
17.4. Becton, Dickinson and Company
17.5. Boston Scientific Corporation
17.6. Cardinal Health, Inc.
17.7. ConMed Corporation
17.8. Cook Group Incorporated
17.9. Danaher Corporation
17.10. Dr. Japan Co., Ltd.
17.11. Fujifilm Holdings Corp.
17.12. Hologic, Inc.
17.13. INRAD, Inc.
17.14. IZI Medical Products
17.15. Johnson & Johnson Services, Inc.
17.16. Medtronic plc
17.17. Merit Medical Systems, Inc.
17.18. MicroPort Scientific Corporation
17.19. Olympus Corporation
17.20. Planmed Oy
17.21. Stryker Corporation
17.22. Summit Medical LLC
17.23. Teleflex Incorporated
17.24. TransMed7, LLC
17.25. Trivitron Healthcare
List of Figures
FIGURE 1. GLOBAL SMART BIOPSY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SMART BIOPSY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SMART BIOPSY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SMART BIOPSY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL SMART BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL SMART BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SMART BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL IMAGING INTEGRATED SMART BIOPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL IMAGING INTEGRATED SMART BIOPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL IMAGING INTEGRATED SMART BIOPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ULTRASOUND INTEGRATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ULTRASOUND INTEGRATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ULTRASOUND INTEGRATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MRI INTEGRATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MRI INTEGRATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MRI INTEGRATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CT INTEGRATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CT INTEGRATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CT INTEGRATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL OPTICAL BIOPSY TECHNOLOGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL OPTICAL BIOPSY TECHNOLOGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL OPTICAL BIOPSY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FLUORESCENCE BASED BIOPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FLUORESCENCE BASED BIOPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FLUORESCENCE BASED BIOPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SPECTROSCOPY BASED BIOPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SPECTROSCOPY BASED BIOPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SPECTROSCOPY BASED BIOPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL AI DRIVEN BIOPSY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL AI DRIVEN BIOPSY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL AI DRIVEN BIOPSY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CANNULAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CANNULAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CANNULAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL COAXIAL SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL COAXIAL SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL COAXIAL SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MARKERS & CLIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MARKERS & CLIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MARKERS & CLIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL LOCALIZATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LOCALIZATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LOCALIZATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PROCEDURE KITS & TRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PROCEDURE KITS & TRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PROCEDURE KITS & TRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NEEDLE-BASED BIOPSY INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NEEDLE-BASED BIOPSY INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NEEDLE-BASED BIOPSY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MINIMALLY INVASIVE BIOPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MINIMALLY INVASIVE BIOPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MINIMALLY INVASIVE BIOPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SURGICAL BIOPSY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SURGICAL BIOPSY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SURGICAL BIOPSY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL BREAST CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BREAST CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL BREAST CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL LIVER CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL LIVER CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL LIVER CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL LUNG CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL LUNG CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL LUNG CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PROSTATE CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL PROSTATE CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PROSTATE CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SKIN CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SKIN CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SKIN CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL MELANOMA DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL MELANOMA DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL MELANOMA DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL NON MELANOMA DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL NON MELANOMA DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NON MELANOMA DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ESOPHAGEAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ESOPHAGEAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ESOPHAGEAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GASTRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GASTRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL GASTRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL COLORECTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL COLORECTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL COLORECTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL KIDNEY CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL KIDNEY CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL KIDNEY CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 156. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 157. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 158. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 159. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 161. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 162. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 164. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 165. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 180. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 181. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 182. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 183. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 184. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 185. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 186. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 188. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 189. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 193. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 194. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 195. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 196. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 197. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 198. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 199. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 201. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 202. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. GCC SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. GCC SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 205. GCC SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 206. GCC SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 207. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 208. GCC SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 209. GCC SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 210. GCC SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 211. GCC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. GCC SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 213. GCC SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 214. GCC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 229. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 230. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 231. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 232. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 233. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 234. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 235. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 237. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 238. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. G7 SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 240. G7 SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 241. G7 SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 242. G7 SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 243. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 244. G7 SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 245. G7 SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 246. G7 SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 247. G7 SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. G7 SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 249. G7 SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 250. G7 SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. NATO SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 252. NATO SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 253. NATO SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 254. NATO SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 255. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 256. NATO SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 257. NATO SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 258. NATO SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 259. NATO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. NATO SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 261. NATO SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 262. NATO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 272. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. CANADA SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 277. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 278. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 279. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 280. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 281. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 282. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 283. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 284. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 285. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 286. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 287. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. MEXICO SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 289. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 290. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 291. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 292. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 293. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 294. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 295. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 296. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 297. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 298. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 299. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. GERMANY SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 326. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 327. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 328. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 329. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 330. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 331. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 332. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 333. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 334. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 335. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 336. FRANCE SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 338. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 339. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 340. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 341. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 342. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 343. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATION LEVEL, 2017-2032 (USD MILLION)
TABLE 344. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 345. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, 2017-2032 (USD MILLION)
TABLE 346. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY GASTROINTESTINAL CANCER, 2017-2032 (USD MILLION)
TABLE 347. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 348. RUSSIA SMART BIOPSY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 349. RUSSIA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 350. RUSSIA SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING INTEGRATED SMART BIOPSY, 2017-2032 (USD MILLION)
TABLE 351. RUSSIA SMART BIOPSY DEVICES MARKET SIZE, BY OPTICAL BIOPSY TECHNOLOGIES, 2017-2032 (USD MILLION)
TABLE 352. RUSSIA SMART BIO

Companies Mentioned

  • Advin Health Care
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • ConMed Corporation
  • Cook Group Incorporated
  • Danaher Corporation
  • Dr. Japan Co., Ltd.
  • Fujifilm Holdings Corp.
  • Hologic, Inc.
  • INRAD, Inc.
  • IZI Medical Products
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Olympus Corporation
  • Planmed Oy
  • Stryker Corporation
  • Summit Medical LLC
  • Teleflex Incorporated
  • TransMed7, LLC
  • Trivitron Healthcare

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.11 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Robotic Biopsy Devices Market - Global Forecast 2026-2032 - Product Image

Robotic Biopsy Devices Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Biopsy Devices Market - Global Forecast 2026-2032 - Product Image

Biopsy Devices Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Biopsy Devices - Global Strategic Business Report - Product Image

Biopsy Devices - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Smart Biopsy Devices Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Smart Biopsy Devices Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Smart Biopsy Device Market

The Smart Biopsy Device market is a subset of the Medical Devices industry. It is composed of products that are used to diagnose and treat diseases and medical conditions. Smart Biopsy Devices are used to collect tissue samples from a patient for further analysis. These devices are designed to be minimally invasive and provide accurate results. They are used in a variety of medical procedures, such as cancer diagnosis and treatment. Smart Biopsy Devices are becoming increasingly popular due to their accuracy and ease of use. The Smart Biopsy Device market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Medtronic, Stryker, Olympus, and Hologic. Other companies in the market include Becton Dickinson, Cook Medical, and Boston Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.